ImmuPharma PLC Appoints Head of Investor Relations
29th February 2012 - 7:00 amImmuPharma PLC (AIM: IMM), the specialist drug development company, is pleased to announce that it has appointed Lisa Baderoon as Head of Investor Relations.
ImmuPharma PLC (AIM: IMM), the specialist drug development company, is pleased to announce that it has appointed Lisa Baderoon as Head of Investor Relations.